Literature DB >> 311703

Dynamics of acute bacterial diseases. Epidemiological models and their application in public health. Part II. Epidemiological models of acute bacterial diseases.

B Cvjetanović, B Grab, K Uemura.   

Abstract

Entities:  

Mesh：

Year:  1978        PMID： 311703      PMCID： PMC2395554     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN： 0042-9686            Impact factor:   9.408


× No keyword cloud information.
  33 in total

1.  Can whooping cough be eradicated?

Authors:  P L Kendrick
Journal:  J Infect Dis       Date:  1975-12       Impact factor: 5.226

2.  [Cutaneous reactions appearing during the mass prophylaxis of cerebrospinal meningitis with a long-delayed action sulfonamide (apropos of 997 cases)].

Authors:  H Bergoend; A Löffler; R Amar; J Maleville
Journal:  Ann Dermatol Syphiligr (Paris)       Date:  1968

3.  A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria.

Authors:  M H Wahdan; S A Sallam; M N Hassan; A Abdel Gawad; A S Rakha; J E Sippel; R Hablas; W R Sanborn; N M Kassem; S M Riad; B Cvjetanović
Journal:  Bull World Health Organ       Date:  1977       Impact factor: 9.408

4.  Treatment of tetanus.

Authors:  I Ildirin; H M Vandiviere
Journal:  Lancet       Date:  1969-06-14       Impact factor: 79.321

5.  Classification of Neisseria meningitidis group B into distinct serotypes. I. Serological typing by a microbactericidal method.

Authors:  C E Frasch; S S Chapman
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

6.  Intravascular Salmonella typhi as a manifestation of the carrier state.

Authors:  K C Watson
Journal:  Lancet       Date:  1967-08-12       Impact factor: 79.321

7.  Skin infections and the epidemiology of diphtheria: acquisition and persistence of C diphtheriae infections.

Authors:  M A Belsey; D R LeBlanc
Journal:  Am J Epidemiol       Date:  1975-08       Impact factor: 4.897

8.  A controlled field trial of a serogroup A meningococcal polysaccharide vaccine.

Authors:  M H Wahdan; F Rizk; A M el-Akkad; A A el-Ghoroury; R Hablas; N I Girgis; A Amer; W Boctar; J E Sippel; E C Gotschlich; R Triau; W R Sanborn; B Cvjetanović
Journal:  Bull World Health Organ       Date:  1973-06       Impact factor: 9.408

9.  A serogroup A meningococcal polysaccharide vaccine: studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A.

Authors:  H H Erwa; M A Haseeb; A A Idris; L Lapeyssonnie; W R Sanborn; J E Sippel
Journal:  Bull World Health Organ       Date:  1973       Impact factor: 9.408

10.  Human immunity to the meningococcus. V. The effect of immunization with meningococcal group C polysaccharide on the carrier state.

Authors:  E C Gotschlich; I Goldschneider; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307
View more
  4 in total

1.  World health situation and trend assessment from 1948 to 1988.

Authors:  K Uemura
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

2.  Impact of hepatitis B immunization strategies on infection rates in Italy: a deterministic computer simulation.

Authors:  P Pasquini; N Delimar; M Kosicek; R De Blasio; R Raschetti; B Cvjetanovic
Journal:  Eur J Epidemiol       Date:  1987-03       Impact factor: 8.082

Review 3.  Vaccines for preventing cholera: killed whole cell or other subunit vaccines (injected).

Authors:  Patricia M Graves; Jonathan J Deeks; Vittorio Demicheli; Tom Jefferson
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

4.  Historical epidemiology of the second cholera pandemic: relevance to present day disease dynamics.

Authors:  Christina H Chan; Ashleigh R Tuite; David N Fisman
Journal:  PLoS One       Date:  2013-08-22       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.